Cargando…
Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness
Auranofin is an oral gold(I) compound, initially developed for the treatment of rheumatoid arthritis. Currently, Auranofin is under investigation for oncological application within a drug repurposing plan due to the relevant antineoplastic activity observed both in vitro and in vivo tumor models. In...
Autores principales: | Gamberi, Tania, Chiappetta, Giovanni, Fiaschi, Tania, Modesti, Alessandra, Sorbi, Flavia, Magherini, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299597/ https://www.ncbi.nlm.nih.gov/pubmed/34850406 http://dx.doi.org/10.1002/med.21872 |
Ejemplares similares
-
Adiponectin Signaling Pathways in Liver Diseases
por: Gamberi, Tania, et al.
Publicado: (2018) -
Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780)
por: Chiappetta, Giovanni, et al.
Publicado: (2022) -
Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues
por: Cirri, Damiano, et al.
Publicado: (2023) -
Adiponectin in Myopathies
por: Gamberi, Tania, et al.
Publicado: (2019) -
Au(2)phen and Auoxo6, Two Dinuclear Oxo-Bridged Gold(III) Compounds, Induce Apoptotic Signaling in Human Ovarian A2780 Cancer Cells
por: Gorini, Giulia, et al.
Publicado: (2021)